Vitamin D supplementation and telomerase activity: a randomized controlled trial
Zhu H, Guo D, Li K, Pedersen-White J, Stallmann-Jorgensen IS, Huang Y, Parikh S, Liu K, Dong Y
Published in International Journal of Obesity
Methodology
Randomized double-blind placebo-controlled trial of vitamin D3 2000 IU/day in overweight African American adults measuring peripheral blood mononuclear cell telomerase activity.
Key Findings
Telomerase activity increased significantly by 19.2% in the vitamin D group with no change on placebo.
Conclusions
Vitamin D supplementation raises telomerase activity.
Limitations
Single ethnic group; surrogate endpoint only.
Supplements Studied
Telomerase activity increased significantly by 19.2% in the vitamin D group with no change on placebo
Outcomes Measured
Telomerase activity increased significantly by 19.2% in the vitamin D group with no change on placebo
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.